This expectation was based on (a) pan-cancer analysis of oncogenes that indicated recurring sets of oncogenic pathways common among various cancers (e.g., kras, TP53), and (b) extrapolation from previous pan-cancer analysis of CNA-associated pathways7. Here, KRAS is linked to cancer.